Skip to main navigation

Overview
News & Events
- Press Releases
- Events and Presentations
Stock Information
- Stock Quote & Chart
- Analyst Coverage
Financials
Governance
IR Resources
- Email Alerts
- Contact IR

Press Releases

Press Releases

Recent Releases

May 16, 2022

Athira Issues Statement in Response to Richard A. Kayne’s Suspension of His Proxy Contest

May 16, 2022

Athira Pharma Presents Preclinical Data at the 2022 Peripheral Nerve Society (PNS) Annual Meeting

May 12, 2022

Athira Pharma Reports First Quarter 2022 Financial Results and Provides Pipeline and Business Updates

Press Releases

Year

October 21, 2021

Athira Pharma Announces Leadership Changes; Mark Litton, Ph.D., M.B.A. Named President and Chief Executive Officer; Rachel Lenington, M.B.A. Named Chief Operating Officer

September 29, 2021

Athira Pharma to Present Updates from Phase 2/3 Trials of ATH-1017 at the 2021 Clinical Trials on Alzheimer’s Disease (CTAD) Conference

August 23, 2021

Athira Pharma to Present on ERP P300 as a Direct, Functional, Non-Invasive Biomarker at the Annual Biomarkers for Alzheimer’s Disease Summit

August 16, 2021

Athira Pharma Reports Second Quarter 2021 Financial Results and Business Update

August 5, 2021

Athira Pharma Mourns the Loss of Chair of Board of Directors, Tadataka Yamada, M.D.

July 19, 2021

Athira Pharma to Present ATH-1017 Phase 1 Translational Data at the Alzheimer’s Association International Conference 2021 (AAIC)

July 6, 2021

Athira Pharma Announces Initiation of Open Label Extension Study for LIFT-AD and ACT-AD Clinical Trials of ATH-1017 for Alzheimer’s Disease

June 17, 2021

Athira Pharma Chief Operating Officer, Mark Litton, Assumes Day-to-Day Leadership Responsibilities of Company

June 14, 2021

Athira Pharma Appoints Rachel Lenington as Chief Technology Officer, Head of Product Development Strategy

June 9, 2021

Athira Pharma to Present at Upcoming Investor Conferences

Pagination

First page
Previous page
Page 1
Page 2
Page 3
Current page 4
Page 5
Page 6
Page 7
Page 8
Next page
Last page

Displaying 31 - 40 of 73

SIGN UP FOR EMAIL ALERTS

CONTACT IR

Athira Pharma, Inc.
18706 North Creek Parkway
Suite 104
Bothell, WA 98011

Main line: (866) 725-0930
Local number: (425) 620-8501
info@athira.com

© Athira Pharma, Inc. All rights reserved.